Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
American Journal of Translational Research|December 14, 2020
Adoptive CD8<sup>+</sup> T cell therapy generates immunological memory to inhibit melanoma metastasisJinfei Fu, Anze Yu, Juyu Tang, et al.
Bioscience Reports|February 26, 2021
Clinicopathological and prognostic significance of osteopontin expression in patients with prostate cancer: a systematic review and meta-analysisAnze Yu, Kai Guo, Qilin Qin, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|July 5, 2023
PD-L1 Expression is Linked to Tumor-Infiltrating T-Cell Exhaustion and Adverse Pathological Behavior in Pheochromocytoma/ParagangliomaAnze Yu, Xiaowen Xu, Yingxian Pang, et al.
Cancer Cell International|May 30, 2020
Clinicopathological and prognostic significance of nestin expression in patients with breast cancer: a systematic review and meta-analysisXinyi Zhang, Changsheng Xing, Wenting Guan, et al.
American Journal of Cancer Research|January 8, 2021
CD4<sup>+</sup> T cell exhaustion leads to adoptive transfer therapy failure which can be prevented by immune checkpoint blockadeJinfei Fu, Anze Yu, Xiang Xiao, et al.
Frontiers in Cellular and Infection Microbiology|June 22, 2026
VSIG2 is associated with an immune-cold microenvironment and reduced response to PD-1 blockade in bladder cancerJihao Wu, Pengyu Liang, Yunbo He, et al.
Oncotarget|February 9, 2018
Long-term follow-up and novel splice donor mutation in <i>MEN1</i> in a Chinese familyMinghao Li, Qianqian Liu, Peihua Liu, et al.
Cell Death & Disease|July 6, 2026
Soluble HER2 promotes chronic antigen-mediated CD8⁺ T-cell dysfunction and limits immunotherapy response in HER2-low triple-negative breast cancerLanyu Jing, Zhiping Tan, Ziling Wang, et al.
Frontiers in Oncology|May 24, 2021
YTHDF1 Is a Potential Pan-Cancer Biomarker for Prognosis and ImmunotherapyJian Hu, Dongxu Qiu, Anze Yu, et al.
Frontiers in Oncology|April 5, 2021
RNA Modification of N6-Methyladenosine Predicts Immune Phenotypes and Therapeutic Opportunities in Kidney Renal Clear Cell CarcinomaHuihuang Li, Jiao Hu, Anze Yu, et al.
Pageof 4